CHAI began working in Tanzania in 2002, helping the government create its National AIDS Control Program to deliver access to lifesaving antiretroviral (ARV) medication, particularly in hard-to-reach rural areas. Today, CHAI works in five areas: HIV, malaria, vaccines, and sexual reproductive health, cancer, health financing and medical oxygen. We are helping to strengthen planning, monitoring, and strategic implementation of immunization services, including COVID 19 vaccination distribution and uptake. We continue to work with the National AIDS Control Program to accelerate the government’s commitment to the UNAIDS 95-95-95 goals. We do so by helping to close the treatment gap for adults, and children with HIV through improved access to viral load monitoring and early infant diagnosis (EID) at the point-of-care. In addition, in partnership with Catholic Relief Services through the Faith-based Action for Scaling up Testing and Treatment for the Epidemic Response (FASTER) project, we support the government to improve testing and treatment for children and adolescents living HIV. We also support health system strengthening for the provision of comprehensive Advanced HIV Disease (AHD) management. With funding from Unitaid, CHAI supports the government to improve the availability of medical oxygen. In other affairs, through the generous support of Comic Relief, we are helping to implement interventions to diagnose and treat febrile illness in children for better management of malaria, pneumonia, and diarrhea - the largest killers of children under five. We are also working to improve planning and resource mobilization for Integrated Reproductive, Maternal, Neonatal, Child and Adolescent Health and Nutrition (RMNCAH&N) interventions, access to family planning new products, and cancer diagnosis as well as treatment options to help save lives and improve economic outcomes for women.
national coverage for COVID-19 vaccination for people 18+ years old as of Dec. 31, 2022
of patients diagnosed with cryptococcal meningitis who have received optimal therapy for management of the disease
increase in modern contraceptive users from 2012 to 2021